ALNY icon

Alnylam Pharmaceuticals
ALNY

Overview Fund Activity

277 hedge funds and large institutions have $7.86B invested in Alnylam Pharmaceuticals in 2015 Q2 according to their latest regulatory filings, with 65 funds opening new positions, 111 increasing their positions, 79 reducing their positions, and 24 closing their positions.

Holders
277
Holders Change
+40
Holders Change %
+16.88%
% of All Funds
7.47%
Holding in Top 10
11
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-8.33%
% of All Funds
0.3%
New
65
Increased
111
Reduced
79
Closed
24
Calls
$95.3M
Puts
$59.8M
Net Calls
+$35.5M
Net Calls Change
+$14.3M

Top Buyers

1
T. Rowe Price Associates
1
T. Rowe Price Associates
Maryland
$205M
2
State Street
2
State Street
Massachusetts
$176M
3
First Trust Advisors
3
First Trust Advisors
Illinois
$186M
4
TCIM
4
TIAA CREF Investment Management
New York
$49.5M
5
Canada Pension Plan Investment Board
5
Canada Pension Plan Investment Board
Ontario, Canada
$27.6M

Top Sellers

1
Wellington Management Group
1
Wellington Management Group
Massachusetts
$1.15B
2
CWAM
2
Columbia Wanger Asset Management
Illinois
$0
3
AWG
3
Alpha Wave Global
New York
$64.5M
4
GGHC
4
Gilder Gagnon Howe & Co
New York
$181M
5
JPMorgan Chase & Co
5
JPMorgan Chase & Co
New York
$35.1M
Name Market Value Shares Shares
Change 		Shares
Change %
Fidelity Investments
1
Fidelity Investments
Massachusetts
$1.52B 12,642,404 +78,383 +0.6%
Wellington Management Group
2
Wellington Management Group
Massachusetts
$1.15B 9,614,040 -826,774 -8%
Vanguard Group
3
Vanguard Group
Pennsylvania
$544M 4,539,997 +212,011 +5%
Capital World Investors
4
Capital World Investors
California
$247M 2,056,603 -82,097 -4%
UBS AM
5
UBS AM
Illinois
$218M 1,815,264 +40,972 +2%
BFA
6
BlackRock Fund Advisors
California
$214M 1,781,765 +89,153 +5%
BIT
7
BlackRock Institutional Trust
California
$210M 1,752,565 -6,769 -0.4%
T. Rowe Price Associates
8
T. Rowe Price Associates
Maryland
$205M 1,711,294 +449,690 +36%
First Trust Advisors
9
First Trust Advisors
Illinois
$186M 1,555,824 +301,299 +24%
GGHC
10
Gilder Gagnon Howe & Co
New York
$181M 1,506,238 -242,129 -14%
State Street
11
State Street
Massachusetts
$176M 1,466,013 +305,414 +26%
Morgan Stanley
12
Morgan Stanley
New York
$156M 1,297,257 -102,268 -7%
BRC
13
Blue Ridge Capital
New York
$129M 1,075,000 +115,000 +12%
Artisan Partners
14
Artisan Partners
Wisconsin
$122M 1,019,280 -65,280 -6%
Franklin Resources
15
Franklin Resources
California
$121M 1,009,997 -116,048 -10%
BB
16
BB Biotech
Switzerland
$116M 965,499 +130,000 +16%
Jennison Associates
17
Jennison Associates
New York
$114M 953,647 +7,800 +0.8%
Baillie Gifford & Co
18
Baillie Gifford & Co
United Kingdom
$94.9M 791,750 -231,680 -23%
Wells Fargo
19
Wells Fargo
California
$88.1M 734,657 -43,368 -6%
Invesco
20
Invesco
Georgia
$84.8M 707,471 +177,724 +34%
SPC
21
Slate Path Capital
New York
$81.7M 681,759 -173,241 -20%
1WCM
22
12 West Capital Management
New York
$78M 651,000 – –
AAMU
23
Amundi Asset Management US
Massachusetts
$75.5M 630,129 +145,305 +30%
BM
24
Bridger Management
New York
$74.8M 623,880 -2,878 -0.5%
Norges Bank
25
Norges Bank
Norway
$68.8M 573,920 -21,374 -4%
1
2 3 4 5